Europe DNA Sequencing Market 2021-2031 by Offering (Instruments, Consumables, Services), Sequencing Type (Sanger, Next-Gen, Others), Technology (Sequencing by Synthesis, Ion Semiconductor, Chain Termination, Pyrosequencing, SBL, SMRT), Application (Biomarker Discovery, Diagnostics, Personalized Medicine, Reproductive Health, Forensics), End User (Research Organizations, Pharma and Biotech Companies, Hospitals & Clinics), and Country: Trend Forecast and Growth Opportunity

Abstract
Europe DNA sequencing market was valued at $ 3,287.4 million in 2021 and will grow by 15.2% annually over 2021-2031, driven by the significant technological advancements, the growth of large-scale sequencing initiatives and support by major governmental funding agencies, the rise in the prevalence of chronic diseases, and the rising applications of DNA sequencing for animal & plant reproduction.

Highlighted with 32 tables and 57 figures, this 109-page report “Europe DNA Sequencing Market 2021-2031 by Offering (Instruments, Consumables, Services), Sequencing Type (Sanger, Next-Gen, Others), Technology (Sequencing by Synthesis, Ion Semiconductor, Chain Termination, Pyrosequencing, SBL, SMRT), Application (Biomarker Discovery, Diagnostics, Personalized Medicine, Reproductive Health, Forensics), End User (Research Organizations, Pharma and Biotech Companies, Hospitals & Clinics), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe DNA sequencing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe DNA sequencing market in every aspect of the classification from perspectives of Offering, Sequencing Type, Technology, Application, End User, and Country.

Based on Offering, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Instruments
•Consumables
•Sequencing Services

Based on Sequencing Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Sanger Sequencing
•Next Generation Sequencing
•Other Sequencing Types

By Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Sequencing by Synthesis
•Ion Semiconductor Sequencing
•Chain Termination Sequencing
•Pyrosequencing
•Sequencing by Ligation (SBL)
•Single-Molecule Real-Time Sequencing (SMRT)
•Nanopore Sequencing
•Other Technologies

By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Biomarker Discovery
•Diagnostics
•Personalized Medicine
•Reproductive Health
•Forensics
•Other Applications

By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Academics and Research Organizations
•Pharmaceutical and Biotechnology Companies
•Hospitals & Clinics
•Other End Users

Geographically, the following national/local markets are fully investigated:
•Germany
•UK
•France
•Spain
•Italy
•Russia
•Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering, Sequencing Type and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:
Agilent Technologies Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories Inc.
Danaher Corporation (Integrated DNA Technologies Inc.)
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd.
Illumina Inc.
Merck KGaA
Pacific Biosciences of California Inc.
PerkinElmer Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Content
Table of Contents

1 Introduction7
1.1 Industry Definition and Research Scope7
1.1.1 Industry Definition7
1.1.2 Research Scope8
1.2 Research Methodology11
1.2.1 Overview of Market Research Methodology11
1.2.2 Market Assumption12
1.2.3 Secondary Data12
1.2.4 Primary Data12
1.2.5 Data Filtration and Model Design13
1.2.6 Market Size/Share Estimation14
1.2.7 Research Limitations15
1.3 Executive Summary16
2 Market Overview and Dynamics19
2.1 Market Size and Forecast19
2.1.1 Impact of COVID-19 on World Economy20
2.1.2 Impact of COVID-19 on the Market22
2.2 Major Growth Drivers24
2.3 Market Restraints and Challenges31
2.4 Emerging Opportunities and Market Trends34
2.5 Porter’s Fiver Forces Analysis38
3 Segmentation of Europe Market by Offering42
3.1 Market Overview by Offering42
3.2 Instruments44
3.3 Consumables45
3.4 Sequencing Services46
4 Segmentation of Europe Market by Sequencing Type47
4.1 Market Overview by Sequencing Type47
4.2 Sanger Sequencing49
4.3 Next Generation Sequencing50
4.4 Other Sequencing Types51
5 Segmentation of Europe Market by Technology52
5.1 Market Overview by Technology52
5.2 Sequencing by Synthesis54
5.3 Ion Semiconductor Sequencing55
5.4 Chain Termination Sequencing56
5.5 Pyrosequencing57
5.6 Sequencing by Ligation (SBL)58
5.7 Single-Molecule Real-Time Sequencing (SMRT)59
5.8 Nanopore Sequencing60
5.9 Other Technologies61
6 Segmentation of Europe Market by Application62
6.1 Market Overview by Application62
6.2 Biomarker Discovery64
6.3 Diagnostics65
6.4 Personalized Medicine66
6.5 Reproductive Health67
6.6 Forensics68
6.7 Other Applications69
7 Segmentation of Europe Market by End User70
7.1 Market Overview by End User70
7.2 Academics and Research Organizations72
7.3 Pharmaceutical and Biotechnology Companies73
7.4 Hospitals & Clinics74
7.5 Other End Users75
8 European Market 2021-2031 by Country76
8.1 Overview of European Market76
8.2 Germany79
8.3 U.K.81
8.4 France83
8.5 Spain85
8.6 Italy87
8.7 Russia89
8.8 Rest of European Market91
9 Competitive Landscape93
9.1 Overview of Key Vendors93
9.2 New Product Launch, Partnership, Investment, and M&A96
9.3 Company Profiles97
Agilent Technologies Inc.97
BGI Genomics Co., Ltd.99
Bio-Rad Laboratories Inc.100
Danaher Corporation (Integrated DNA Technologies Inc.)101
Eurofins Scientific SE102
F. Hoffmann-La Roche Ltd.103
Illumina Inc.104
Merck KGaA105
Pacific Biosciences of California Inc.106
PerkinElmer Inc.107
Thermo Fisher Scientific Inc.108
RELATED REPORTS109

List of Tables:

Table 1. Snapshot of Europe DNA Sequencing Market in Balanced Perspective, 2021-203117
Table 2. World Economic Outlook, 2021-203121
Table 3. World Health Spending by Region, $ bn, 2013-202030
Table 4. Main Product Trends and Market Opportunities in Europe DNA Sequencing Market34
Table 5. Europe DNA Sequencing Market by Offering, 2021-2031, $ mn42
Table 6. Europe DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn47
Table 7. Europe DNA Sequencing Market by Technology, 2021-2031, $ mn52
Table 8. Europe DNA Sequencing Market by Application, 2021-2031, $ mn62
Table 9. Europe DNA Sequencing Market by End User, 2021-2031, $ mn70
Table 10. Europe DNA Sequencing Market by Country, 2021-2031, $ mn78
Table 11. Germany DNA Sequencing Market by Offering, 2021-2031, $ mn80
Table 12. Germany DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn80
Table 13. Germany DNA Sequencing Market by End User, 2021-2031, $ mn80
Table 14. U.K. DNA Sequencing Market by Offering, 2021-2031, $ mn82
Table 15. U.K. DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn82
Table 16. U.K. DNA Sequencing Market by End User, 2021-2031, $ mn82
Table 17. France DNA Sequencing Market by Offering, 2021-2031, $ mn84
Table 18. France DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn84
Table 19. France DNA Sequencing Market by End User, 2021-2031, $ mn84
Table 20. Spain DNA Sequencing Market by Offering, 2021-2031, $ mn86
Table 21. Spain DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn86
Table 22. Spain DNA Sequencing Market by End User, 2021-2031, $ mn86
Table 23. Italy DNA Sequencing Market by Offering, 2021-2031, $ mn88
Table 24. Italy DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn88
Table 25. Italy DNA Sequencing Market by End User, 2021-2031, $ mn88
Table 26. Russia DNA Sequencing Market by Offering, 2021-2031, $ mn90
Table 27. Russia DNA Sequencing Market by Sequencing Type, 2021-2031, $ mn90
Table 28. Russia DNA Sequencing Market by End User, 2021-2031, $ mn90
Table 29. DNA Sequencing Market in Rest of Europe by Country, 2021-2031, $ mn92
Table 30. Agilent Technologies Inc.: Company Snapshot97
Table 31. Agilent Technologies Inc.: Business Segmentation98
Table 32. Agilent Technologies Inc.: Product Portfolio98